Amend Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Ujjain, Madhya Pradesh, India, established in 1998.
1998 Ujjain, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Amend Drugs Private Limited

Amend Drugs Private Limited, a struck off private limited company, was established on 02 February 1998 in Ujjain, Madhya Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MP1998PTC012988. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Virendra Singh Panwar (Director), Uttam Panwar (Director). It holds no open charges and ₹1.90 M settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 104-Arya Samaj Marg, Ujjain, Madhya Pradesh, 456001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP1998PTC012988

  • Registration Number

    012988

  • Incorporation Date

    02 February 1998

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 28 Year, 12 Days
  • Last Filing with ROC 31 Mar 2013
  • Satisfied Charges ₹ 1.90 M
Company report

Amend Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amend Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Amend Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Virendra Singh Panwar Director 07 Apr 2006 Current
Uttam Panwar Director 10 Aug 1998 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amend Drugs.

Enhance accessibility to Amend Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Amend Drugs revenue growth over time
Amend Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amend Drugs?

Unlock access to Amend Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,900,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.19 Cr
Latest Charge Details
Date Lender Amount Status
23 Jul 1999 State Bank Of India ₹1.90 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Amend Drugs?

Unlock and access historical data on people associated with Amend Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amend Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amend Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amend Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 23 Jul 1999 via Charge ID 90208461 with State Bank Of India was fully satisfied on 29 May 2018. was documented.

  • Annual General Meeting

    The activity Amend Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Amend Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Gwalior. was documented.

  • Director Appointment

    Progress on Virendra Singh Panwar was appointed as a Director was appointed as a Director on 07 Apr 2006 & has been associated with this company since 19 years 10 months . was documented.

  • Charges

    A charge with State Bank Of India of Rs. 1.90 M registered on 23 Jul 1999 with Charge ID 90208461 was modified on 21 May 2005. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 1.90 M with Charge ID 90208461 was registered on 23 Jul 1999. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Amend Drugs Private Limited?

The CIN of Amend Drugs Private Limited is U24232MP1998PTC012988.

Where is Amend Drugs Private Limited headquartered?

Amend Drugs Private Limited is headquartered at 104-Arya Samaj Marg, Ujjain, Madhya Pradesh, 456001.

When was Amend Drugs Private Limited incorporated?

Amend Drugs Private Limited was incorporated on 02 February 1998.

Who are the current directors of Amend Drugs Private Limited?

The current directors of Amend Drugs Private Limited are

What is the primary industry of Amend Drugs Private Limited?

The primary industry of Amend Drugs Private Limited is Chemicals.

Is Amend Drugs Private Limited a listed company?

Amend Drugs Private Limited is unlisted.

What is the capital structure of Amend Drugs Private Limited?

The authorized capital of Amend Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available